Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease

被引:81
|
作者
Pablo Arab, Juan [1 ]
Dirchwolf, Melisa [2 ]
Alvares-da-Silva, Mario Reis [3 ,4 ,5 ]
Barrera, Francisco [1 ]
Benitez, Carlos [1 ]
Castellanos-Fernandez, Marlene [6 ]
Castro-Narro, Graciela [7 ]
Chavez-Tapia, Norberto [8 ]
Chiodi, Daniela [9 ]
Cotrim, Helma [10 ]
Cusi, Kenneth [11 ]
Marques Souza de Oliveira, Claudia Pinto [12 ]
Diaz, Javier [13 ]
Fassio, Eduardo [14 ]
Gerona, Solange [15 ]
Girala, Marcos [16 ]
Hernandez, Nelia [9 ]
Marciano, Sebastian [17 ]
Masson, Walter [18 ]
Mendez-Sanchez, Nahum [8 ]
Leite, Nathalie [19 ,20 ]
Lozano, Adelina [21 ,22 ]
Padilla, Martin [23 ]
Panduro, Arturo [24 ]
Parana, Raymundo [10 ]
Parise, Edison [25 ]
Perez, Marlene [26 ]
Poniachik, Jaime [27 ]
Carlos Restrepo, Juan [28 ,29 ]
Ruf, Andres [2 ]
Silva, Marcelo [30 ]
Tagle, Martin [31 ]
Tapias, Monica [32 ]
Torres, Kenia [26 ]
Vilar-Gomez, Eduardo [33 ]
Costa Gil, Jose Eduardo [34 ]
Gadano, Adrian [17 ]
Arrese, Marco [1 ]
机构
[1] Pontificia Univ Catolica Chile, Dept Gastroenterol, Escuela Med, Santiago, Chile
[2] Hosp Privado Rosario, Serv Hepatol, Unidad Trasplante Hepat, Rosario, Santa Fe, Argentina
[3] Hosp Clin Porto Alegre, Hepatol Div, Porto Alegre, RS, Brazil
[4] Univ Fed Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil
[5] Univ Fed Rio Grande do Sul, Grad Program Gastroenterol & Hepatol, Porto Alegre, RS, Brazil
[6] Natl Inst Gastroenterol, Dept Res & Teaching, Havana, Cuba
[7] Natl Inst Med Sci & Nutr Salvador Zubiran, Gastroenterol Dept, Mexico City, DF, Mexico
[8] Med Sur Clin & Fdn, Liver Res Unit, Mexico City, DF, Mexico
[9] Univ Republica, Hosp Clin, Fac Med, Montevideo, Uruguay
[10] Univ Fed Bahia, Sch Med, Salvador, BA, Brazil
[11] Univ Florida, Div Endocrinol Diabet & Metab, Gainesville, FL USA
[12] Univ Sao Paulo, Dept Gastroenterol, Clin Div, Hepatol Branch,Sch Med, Sao Paulo, Brazil
[13] Hosp Edgardo Rebagliati Martins, Dept Aparato Digest, EsSalud, Lima, Peru
[14] Hosp Nacl Prof Alejandro Posadas, Serv Gastroenterol, Secc Higado Vias Biliares & Pancreas, Buenos Aires, DF, Argentina
[15] Hosp Fuerzas Armadas, Liver Unit, Montevideo, Uruguay
[16] Hosp Clinicas, Asuncion, Paraguay
[17] Hosp Italiano Buenos Aires, Liver Unit, Buenos Aires, DF, Argentina
[18] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[19] Univ Fed Rio de Janeiro, Internal Med Dept, Sch Med, Rio De Janeiro, Brazil
[20] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Rio De Janeiro, Brazil
[21] Hosp Nacl Arzobispo Loayza, Serv Gastroenterol, Unidad Higado, Lima, Peru
[22] Univ Peruana Cayetano Heredia, Lima, Peru
[23] Hosp Guillermo Almenara, Lima, Peru
[24] Civil Hosp Guadalajara, Dept Mol Biol Med, Guadalajara, Jalisco, Mexico
[25] Univ Fed Sao Paulo, Dept Gastroenterol, Sao Paulo, Brazil
[26] Hosp Gen Plaza Salud, Santo Domingo, Dominican Rep
[27] Hosp Clin Univ Chile, Secc Gastroenterol, Santiago, Chile
[28] Univ Antioquia, Hepatobiliary & Liver Transplant Program, Hosp Pablo Tobon Uribe, Medellin, Colombia
[29] Univ Antioquia UdeA, Fac Med, Grp Gastrohepatol, Medellin, Colombia
[30] Hosp Univ Austral, Hepatol & Liver Transplant Unit, Pilar, Argentina
[31] Univ Peruana Cayetano Heredia, Fac Med Alberto Hurtado, Lima, Peru
[32] Hosp Univ Fdn Santa Fe Bogota, Bogota, Colombia
[33] Indiana Univ Sch Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA
[34] Univ Favaloro, Fac Ciencias Med, Buenos Aires, DF, Argentina
关键词
Steatosis; NAFLD; NASH; Fatty liver; Clinical practice guidance; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; MAFLD; Cirrhosis; HEPATOCELLULAR-CARCINOMA; CARDIOVASCULAR-DISEASE; VITAMIN-E; INSULIN-RESISTANCE; SCORING SYSTEM; NONINVASIVE DIAGNOSIS; ALCOHOL-CONSUMPTION; METABOLIC SYNDROME; FIBROSIS STAGE; STEATOHEPATITIS;
D O I
10.1016/j.aohep.2020.09.006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20-30% of the general population. Furthermore, its prevalence is predicted to increase exponentially in the next decades, concomitantly with the global epidemic of obesity, type 2 diabetes mellitus (T2DM), and sedentary lifestyle. NAFLD is a clinical syndrome that encompasses a wide spectrum of associated diseases and hepatic complications such as hepatocellular carcinoma (HCC). Moreover, this disease is believed to become the main indication for liver transplantation in the near future. Since NAFLD management represents a growing challenge for primary care physicians, the Asociacion Latinoamericana para el Estudio del Higado (ALEH) has decided to organize this Practice Guidance for the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease, written by Latin-American specialists in different clinical areas, and destined to general practitioners, internal medicine specialists, endocrinologists, diabetologists, gastroenterologists, and hepatologists. The main purpose of this document is to improve patient care and awareness of NAFLD. The information provided in this guidance may also be useful in assisting stakeholders in the decision-making process related to NAFLD. Since new evidence is constantly emerging on different aspects of the disease, updates to this guideline will be required in future. (C) 2020 Published by Elsevier Espana, S.L.U. on behalf of Fundacion Cilnica Medica Sur, A.C.
引用
收藏
页码:674 / 690
页数:17
相关论文
共 50 条
  • [31] Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why liver biopsy is essential
    Bedossa, Pierre
    LIVER INTERNATIONAL, 2018, 38 : 64 - 66
  • [32] NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC FATTY PANCREAS DISEASE: A NEW INTRIGUING ASSOCIATION?
    Della Corte, Claudia
    Mosca, Antonella
    Sartorelli, Maria Rita
    Comparcola, Donatella
    Liccardo, Daniela
    Alterio, Arianna
    Lucidi, Vincenzina
    Nobili, Valerio
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : E101 - E101
  • [33] The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
    Chalasani, Naga
    Younossi, Zobair
    Lavine, Joel E.
    Charlton, Michael
    Cusi, Kenneth
    Rinella, Mary
    Harrison, Stephen A.
    Brunt, Elizabeth M.
    Sanyal, Arun J.
    HEPATOLOGY, 2018, 67 (01) : 328 - 357
  • [34] Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis
    Sharma, Praveen
    Arora, Anil
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 5
  • [35] Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver
    Loguercio, C
    De Simone, T
    D'Auria, MV
    de Sio, I
    Federico, A
    Tuccillo, C
    Abbatecola, AM
    Blanco, CD
    DIGESTIVE AND LIVER DISEASE, 2004, 36 (06) : 398 - 405
  • [36] Surgical Treatment of Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease
    Weiner, R. A.
    DIGESTIVE DISEASES, 2010, 28 (01) : 274 - 279
  • [37] The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association (vol 107, pg 811, 2012)
    Chalasani, Naga
    Younossi, Zobair
    Lavine, Joel E.
    Diehl, Anna Mae
    Brunt, Elizabeth M.
    Cusi, Kenneth
    Charlton, Michael
    Sanyal, Arun J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (10): : 1598 - 1598
  • [38] The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology (vol 142, pg, 1592, 2012)
    Chalasani, N.
    Younossi, Z.
    Lavine, J. E.
    GASTROENTEROLOGY, 2012, 143 (02) : 503 - 503
  • [39] Current treatment of non-alcoholic fatty liver disease
    Ahmed, Mohamed H.
    Byrne, Christopher D.
    DIABETES OBESITY & METABOLISM, 2009, 11 (03): : 188 - 195
  • [40] Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
    Francque, Sven
    Vonghia, Luisa
    ADVANCES IN THERAPY, 2019, 36 (05) : 1052 - 1074